Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.34 |
| ▸ | RGS12 | O14924 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | EBP | Q15125 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL868069 | 1.00 | GNAI3 (0.41) | GNAI3GNAO1GNAI1TSHRTHRB | |
| Water SCHEMBL2526562 | 0.98 | GNAI3 (0.40) | GNAI3GNAO1GNAI1TSHRTHRB | |
| Iodide SCHEMBL3854066 | 0.98 | GNAI3 (0.40) | GNAI3GNAO1GNAI1TSHRTHRB | |
| Bromide SCHEMBL2524389 | 0.98 | GNAI3 (0.40) | GNAI3GNAO1GNAI1TSHRTHRB | |
| SCHEMBL1666073 | 0.88 | CHRNA7 (0.36) | CHRNA7 | |
| Acetic Acid SCHEMBL5368078 | 0.87 | CES2 (0.36) | GNAI3GNAO1GNAI1APOBEC3AAPOBEC3G | |
| SCHEMBL7263081 | 0.85 | CHRNA7 (0.38) | CHRNA7 | |
| Bromide SCHEMBL7629729 | 0.83 | CHRNA7 (0.36) | CHRNA7 | |
| Bromide SCHEMBL22788428 | 0.80 | TSHR (0.44) | GNAI3GNAO1GNAI1TSHRTHRB | |
| SCHEMBL18845451 | 0.80 | TSHR (0.41) | GNAI3GNAO1GNAI1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1687241-B1 | USE OF EUO STRUCTURAL ZEOLITE CONTAINING AN HEXYLQUINUCLIDINIUM STRUCTURING AS CATALYST | INST FRANCAIS DU PETROLE (FR) | 2012-05-02 | — | — | EP | claimed |
| US-8038982-B2 | EUO-structural-type zeolite containing the alkyl quinuclidinium structuring agent, process for preparation and use as catalyst | IFP Energies Nouvelles (FR) | 2011-10-18 | — | — | US | claimed |
| US-20090043145-A1 | Euo-structural-type zeolite containing the alkyl quinuclidinium structuring agent, process for preparation and use as catalyst | INSTITUT FRANCAIS DU PETROLE (FR) | 2009-02-12 | — | — | US | claimed |
| JP-2007513040-A | — | — | 2007-05-24 | — | — | JP | claimed |
| EP-1687241-A2 | EUO STRUCTURAL ZEOLITE CONTAINING AN ALKYLQUINUCLIDINIUM STRUCTURING, METHOD FOR THE PREPARATION AND USE THEREOF IN THE FORM OF A CATALYST | Institut Français du Pétrole (FR) | 2006-08-09 | — | — | EP | claimed |
| WO-2005049494-A2 | EUO STRUCTURAL ZEOLITE CONTAINING AN ALKYLQUINUCLIDINIUM STRUCTURING, METHOD FOR THE PREPARATION AND USE THEREOF IN THE FORM OF A CATALYST | INSTITUT FRANCAIS DU PETROLE (FR) | 2005-06-02 | — | — | WO | claimed |
| US-9549549-B2 | Antimicrobial materials and methods | STC.UNM (US) | 2017-01-24 | — | — | US | disclosed |
| US-20140242148-A1 | ANTIMICROBIAL MATERIALS AND METHODS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-08-28 | — | — | US | disclosed |
| EP-1687241-B1 | USE OF EUO STRUCTURAL ZEOLITE CONTAINING AN HEXYLQUINUCLIDINIUM STRUCTURING AS CATALYST | INST FRANCAIS DU PETROLE (FR) | 2012-05-02 | — | — | EP | disclosed |
| US-8038982-B2 | EUO-structural-type zeolite containing the alkyl quinuclidinium structuring agent, process for preparation and use as catalyst | IFP Energies Nouvelles (FR) | 2011-10-18 | — | — | US | disclosed |
| US-20090043145-A1 | Euo-structural-type zeolite containing the alkyl quinuclidinium structuring agent, process for preparation and use as catalyst | INSTITUT FRANCAIS DU PETROLE (FR) | 2009-02-12 | — | — | US | disclosed |
| EP-1687241-A2 | EUO STRUCTURAL ZEOLITE CONTAINING AN ALKYLQUINUCLIDINIUM STRUCTURING, METHOD FOR THE PREPARATION AND USE THEREOF IN THE FORM OF A CATALYST | Institut Français du Pétrole (FR) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005049494-A2 | EUO STRUCTURAL ZEOLITE CONTAINING AN ALKYLQUINUCLIDINIUM STRUCTURING, METHOD FOR THE PREPARATION AND USE THEREOF IN THE FORM OF A CATALYST | INSTITUT FRANCAIS DU PETROLE (FR) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140242148-A1 | ANTIMICROBIAL MATERIALS AND METHODS | AOC3, OGFOD1, DDT | GNAI3 3020/4885GNAO1 2555/4885GNAI1 3606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.